These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12464151)

  • 1. Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
    Frieling U; Luger TA
    Clin Exp Dermatol; 2002 Oct; 27(7):562-70. PubMed ID: 12464151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G; Pfeiffer C
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
    Wennberg L; Groth CG; Tibell A; Zhu S; Liu J; Rafael E; Söderlund J; Biberfeld P; Morris RE; Karlsson-Parra A; Korsgren O
    Transplant Proc; 1997 Aug; 29(5):2498. PubMed ID: 9270824
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
    Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA
    Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
    Liu XW; Li DM; Xu GS; Sun SR
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):509-13. PubMed ID: 20650041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L; Song Z; Zhang J; Bennet W; Nava S; Bari S; Sundberg B; Korsgren O; Groth CG
    Transplant Proc; 2000 Aug; 32(5):1061. PubMed ID: 10936353
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR
    Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide in dermatology.
    Boyd AS
    J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
    Gaudy-Marqueste C
    Ann Dermatol Venereol; 2007 Dec; 134(12):949-56. PubMed ID: 18166916
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1996 Apr; 28(2):819. PubMed ID: 8623416
    [No Abstract]   [Full Text] [Related]  

  • 17. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
    Assmann T; Ruzicka T
    Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil in dermatology.
    Orvis AK; Wesson SK; Breza TS; Church AA; Mitchell CL; Watkins SW
    J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Fragoso YD; Brooks JB
    Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil.
    Heymann WR
    J Am Acad Dermatol; 2005 Dec; 53(6):1045-6. PubMed ID: 16310066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.